首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Substance use & addiction journal

缩写:SUBST USE ADDICT J

ISSN:2976-7342

e-ISSN:2976-7350

IF/分区:2.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引362条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Riley D Shearer,Edith Hernandez,Timothy J Beebe et al. Riley D Shearer et al.
Background: The overdose crisis is increasingly characterized by opioid and stimulant co-use. Despite effective pharmacologic treatment for both opioid use disorder (OUD) and contingency management for stimulant use disor...
Catherine Callister,Samuel Porter,Phillip Vatterott et al. Catherine Callister et al.
Background: Treating opioid use disorder (OUD) with buprenorphine or methadone significantly reduces overdose and all-cause mortality. Prior studies demonstrate that clinicians and residents reported a lack of preparednes...
Katelyn F Romm,Carla J Berg Katelyn F Romm
Introduction: Adverse childhood experiences (ACEs) predict problematic health outcomes (eg, substance use, mental health) among young adults; whether specific ACEs are differentially associated with specific substance use...
Jill M Singer,Alayna P Tackett,Elizabeth G Klein et al. Jill M Singer et al.
Background: Among adolescents and young adults (AYAs), "current use" of electronic cigarettes (e-cigarettes) is commonly defined as any use in the past 30 days. However, few studies have examined differences among those w...
Adam Viera,Ashlin Ondrusek,Cecil Tengatenga et al. Adam Viera et al.
Background: The use of tracking technology in substance use research can uncover the role of contextual factors, such as social networks and environmental cues, in triggering cravings and precipitating return to use. Few ...
Alysson E Light,Traci C Green,Patricia R Freeman et al. Alysson E Light et al.
Background: Concerns have been raised that pharmacists sometimes act as barriers to patients with opioid use disorder (OUD) accessing buprenorphine treatment. The present research explores how community pharmacists' endor...
Jennifer J Carroll Jennifer J Carroll
Background: Xylazine, an adrenergic alpha-2 agonist increasingly present in the US drug supply, is associated with severe skin ulcers and other harms. Expert knowledge from front-line harm reduction and healthcare profess...
Jenna Langlois,Seonaid Nolan,Piper Dickhout et al. Jenna Langlois et al.
North America is facing an unprecedented public health emergency of opioid-related morbidity and mortality. The mortality benefits of oral medication treatment for opioid use disorder (MOUD), such as methadone or buprenorphine, are well doc...
Nora Satybaldiyeva,Erin Delker,Gretchen Bandoli Nora Satybaldiyeva
Background: Drug and alcohol use before the age of 14 is associated with adverse outcomes over the life course. While previous studies have identified numerous sociodemographic characteristics associated with youth substa...
Bethany Canver,Alayna Liptak,Katie Clark et al. Bethany Canver et al.
Background: Physicians in internal medicine lack comfort and skills required to diagnose and treat substance use disorder (SUD). Formal training in substance use treatment within primary care training has traditionally be...